Suchergebnisse für 药物处方手册（...
Beispielbild für diese ISBN
Drug Formulary (second edition)(Chinese Edition)
ISBN 10: 7535772528
ISBN 13: 9787535772527
Neu
paperback
Anbieter: liu xing, Nanjing, JS, China
Verkäuferbewertung 5 von 5 Sternen
paperback. Zustand: New. Ship out in 2 business day, And Fast shipping, Free Tracking number will be provided after the shipment.Paperback. Pub Date :2012-06-01 Pages: 1279 Publisher: Hunan Science and Technology Press title: Drug Formulary (Second Edition) List Price: 39.80 yuan Author: Nobutaka governance. Chao. Zhu Yungui editor Publisher: Hunan Science and Technology Publishing Date :2012-6-1ISBN: 9787535772527 Words: 1.47 million yards: 1279 Revision: 1 Binding: Paperback: 32 Weight: Editor's Summary based on clinical actual needs of the selection of the national health units commonly efficacy drug a total of more than 2.600 kinds of characteristics of the pharmacological effects is divided into 34 chapters. each chapter before a brief overview. followed by introduction of each drug. the drug name. alias. preparation. role. clinical application. usage. dosage. adverse reactions. disable caution and prescription instructions. Nobutaka governance. Chao. Zhu Yungui editor of the Drug Formulary (2) remove part of unused drugs. such as phenylpropanolamine. aprotinin on the basis of the first edition. the new increased approximately 600 drugs . antibiotics and circulatory system drugs. anticancer drugs. such as part of the adjustment. Reprinted after this manual to better meet the clinical needs more welcomed by readers. Table of Contents Chapter antimicrobial drugs first antibiotic Section II of section III of synthetic antibacterial agents anti-TB drugs anti-leprosy drugs section V. Section IV antifungal Chinese medicine antimicrobial antiviral Section VI Section VII Chapter II the antiparasitic the first section antimalarial Section II anti-amebic drugs antitrichomonal drug Section III Section IV anti-Leishmania donovani drug resistant flukes drug and anti-filarial drug Section 5 drive intestinal worm medicine Section III of Chapter III of antipyretic analgesics. anti-rheumatic drugs and anti-gout drug compound preparation of the section I. section II. antipyretic analgesics and anti-rheumatic drugs antipyretic analgesics in section IV anti-gout anti-rheumatic drugs drug Chapter IV of analgesics Section narcotic analgesic non-narcotic analgesics Section II Section III treatment of migraine drug Chapter central nervous system stimulant and central muscle relaxants Section 1 central nervous system stimulant Section IV decarboxylase inhibitor drug section II. central muscle relaxant Section I of Chapter VI of the drug anti-Parkinson's disease (syndrome) drug anti-acetylcholine the drug Section II increased brain dopamine content medicine Section III brain dopamine receptors agonists of Section V monoamine oxidase inhibitors Section VI catecholamine an O-methyl transferase inhibition of Chapter VIII of the Chapter VII of the drug section VII of other drugs affect the brain blood vessels. metabolism and nootropics cholinergic drugs and anticholinergic drugs Section I Section II of Chapter anticholinergics antiepileptic drugs cholinergic drugs Chapter X sedative hypnotic and anxiolytic first barbiturates in section III of Section II of benzodiazepine leather medicines other drugs Section I of Chapter 11 anti-psychiatric disorder drug antipsychotic the Section II antidepressants Section III Chapter 12 anesthetics anti-manic drugs assisted local anesthetic first drug first general anesthetic Section II Section IV of the three muscle relaxants narcotic antagonist drug Chapter XIII circulatory system drugs first section anti-heart failure drugs the second antiarrhythmic drugs Section III antihypertensives Section IV anti-angina drug section V. anti-shock drug Section VI Section VII anti-platelet aggregation drugs and antithrombotic drugs section VIII. improve nutrition and drug metabolism of other drugs of the Section IX Chapter XIV respiratory medication first section antitussives Section II expectorant lipid regulating drugs medicine the third quarter and asthma medicine Section IV Chapter 15 of the other drugs. digestive system drugs the first section anta. Bestandsnummer des Verkäufers EJ020866